Sodium channel dysfunction in inherited and acquired cardiac diseases

Background— The mechanism of ECG changes and arrhythmogenesis in Brugada syndrome (BS) patients is unknown. Methods and Results— A BS patient without clinically detected cardiac structural abnormalities underwent cardiac transplantation for intolerable numbers of implantable cardioverter/defibrillator discharges. The patient’s explanted heart was studied electrophysiologically and histopathologically. Whole-cell currents were measured in HEK293 cells expressing wild-type or mutated sodium channels from the patient. The right ventricular outflow tract (RVOT) endocardium showed activation slowing and was the origin of ventricular fibrillation without a transmural repolarization gradient. Conduction restitution was abnormal in the RVOT but normal in the left ventricle. Right ventricular hypertrophy and fibrosis with epicardial fatty infiltration were present. HEK293 cells expressing a G1935S mutation in the gene encoding the cardiac sodium channel exhibited enhanced slow inactivation compared with wild-type channels. Computer simulations demonstrated that conduction slowing in the RVOT might have been the cause of the ECG changes. Conclusions— In this patient with BS, conduction slowing based on interstitial fibrosis, but not transmural repolarization differences, caused the ECG signs and was the origin of ventricular fibrillation.

[1]  A. Wilde,et al.  Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. , 2005, Acta physiologica Scandinavica.

[2]  D. Corrado,et al.  Right Bundle Branch Block, Right Precordial ST-Segment Elevation, and Sudden Death in Young People , 2001, Circulation.

[3]  C Antzelevitch,et al.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. , 1999, Circulation research.

[4]  Cornelis A. Grimbergen,et al.  Software design for analysis of multichannel intracardial and body surface electrocardiograms , 2002, Comput. Methods Programs Biomed..

[5]  R. Virmani,et al.  Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? , 1998, Circulation.

[6]  Lucas J Herfst,et al.  Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System , 2003, Circulation research.

[7]  S. Priori,et al.  Clinical and Genetic Heterogeneity of Right Bundle Branch Block and ST-Segment Elevation Syndrome: A Prospective Evaluation of 52 Families , 2000, Circulation.

[8]  S. Peters,et al.  Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy. , 2004, International journal of cardiology.

[9]  Bortolo Martini,et al.  Brugada by any other name? , 2001, European heart journal.

[10]  G. Breithardt,et al.  Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. , 2002, Journal of the American College of Cardiology.

[11]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[12]  A. Wilde,et al.  Delay in Right Ventricular Activation Contributes to Brugada Syndrome , 2004, Circulation.

[13]  L. Hondeghem,et al.  Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback. , 1990, Circulation.

[14]  Bortolo Martini,et al.  1988-2003. Fifteen years after the first Italian description by Nava-Martini-Thiene and colleagues of a new syndrome (different from the Brugada syndrome?) in the Giornale Italiano di Cardiologia: do we really know everything on this entity? , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.

[15]  G. Moe.  Oscillating concepts in arrhythmia research; a personal account. , 1984, International journal of cardiology.

[16]  Walter Birchmeier,et al.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.

[17]  J. D. de Bakker,et al.  Impaired Impulse Propagation in Scn5a-Knockout Mice: Combined Contribution of Excitability, Connexin Expression, and Tissue Architecture in Relation to Aging , 2005, Circulation.

[18]  A. van Oosterom,et al.  ECGSIM: an interactive tool for studying the genesis of QRST waveforms , 2004, Heart.

[19]  R. Hauer,et al.  Proposed diagnostic criteria for the Brugada syndrome: consensus report. , 2002, Circulation.

[20]  Ruben Coronel,et al.  Activation Delay After Premature Stimulation in Chronically Diseased Human Myocardium Relates to the Architecture of Interstitial Fibrosis , 2001, Circulation.

[21]  U. Gerckens,et al.  [Brugada syndrome or ARVD (arrhythmogenic right ventricular dysplasia) or both? Significance and value of right precordial ECG changes]. , 2002, Zeitschrift fur Kardiologie.

[22]  P. C. Viswanathan,et al.  Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. , 2000, Circulation research.

[23]  U. Gerckens,et al.  Brugada-Syndrom oder ARVD oder beides? Bedeutung und Wertigkeit rechtspräkordialer EKG-Veränderungen , 2002, Zeitschrift für Kardiologie.

[24]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[25]  D. Corrado,et al.  Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. , 1996, Journal of the American College of Cardiology.

[26]  Proposed diagnostic criteria for the Brugada syndrome. , 2002, European heart journal.

[27]  P. Brugada,et al.  Heart Transplantation as Last Resort Against Brugada Syndrome , 2002, Journal of cardiovascular electrophysiology.

[28]  R. Coronel,et al.  Laplacian Electrograms and the Interpretation of Complex Ventricular Activation Patterns During Ventricular Fibrillation , 2000, Journal of cardiovascular electrophysiology.

[29]  G. Steinbeck,et al.  Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. , 1996, Circulation.

[30]  R. Lux,et al.  Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms. Effects of interventions that alter repolarization time. , 1990, Circulation.

[31]  G. Danieli,et al.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.

[32]  A. Iwasa,et al.  Mechanism of ST Elevation and Ventricular Arrhythmias in an Experimental Brugada Syndrome Model , 2003, Circulation.

[33]  R. C. Saumarez,et al.  Ventricular Fibrillation in Hypertrophic Cardiomyopathy Is Associated With Increased Fractionation of Paced Right Ventricular Electrograms , 1992, Circulation.

[34]  H Kasanuki,et al.  Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. , 1997, Circulation.

[35]  Jeffrey L. Anderson,et al.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.

[36]  T. Opthof,et al.  Reperfusion arrhythmias in isolated perfused pig hearts. Inhomogeneities in extracellular potassium, ST and TQ potentials, and transmembrane action potentials. , 1992, Circulation research.

[37]  J. Brugada,et al.  Brugada syndrome: a decade of progress. , 2002, Circulation research.

[38]  H. Morita,et al.  Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. , 2002, Journal of the American College of Cardiology.

[39]  D. Roden,et al.  Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoter. , 2004, Cardiovascular research.